Center of Nanotechnology, King Abdulaziz University, Jeddah, Saudi Arabia.
Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia.
Sci Rep. 2020 Nov 24;10(1):20428. doi: 10.1038/s41598-020-76971-w.
Non-healing wounds have placed an enormous stress on both patients and healthcare systems worldwide. Severe complications induced by these wounds can lead to limb amputation or even death and urgently require more effective treatments. Electrospun scaffolds have great potential for improving wound healing treatments by providing controlled drug delivery. Previously, we developed fibrous scaffolds from complex carbohydrate polymers [i.e. chitin-lignin (CL) gels]. However, their application was limited by solubility and undesirable burst drug release. Here, a coaxial electrospinning is applied to encapsulate the CL gels with polycaprolactone (PCL). Presence of a PCL shell layer thus provides longer shelf-life for the CL gels in a wet environment and sustainable drug release. Antibiotics loaded into core-shell fibrous platform effectively inhibit both gram-positive and -negative bacteria without inducting observable cytotoxicity. Therefore, PCL coated CL fibrous gel platforms appear to be good candidates for controlled drug release based wound dressing applications.
非愈合性伤口给全世界的患者和医疗系统带来了巨大的压力。这些伤口引起的严重并发症可导致截肢,甚至死亡,因此迫切需要更有效的治疗方法。电纺支架通过提供控制药物释放,在改善伤口愈合治疗方面具有巨大的潜力。此前,我们曾从复杂碳水化合物聚合物(如甲壳素-木质素(CL)凝胶)中开发出纤维支架。然而,其应用受到溶解度和不理想的药物突释的限制。在此,我们采用同轴静电纺丝将 CL 凝胶包封在聚己内酯(PCL)中。因此,PCL 壳层的存在为湿润环境中的 CL 凝胶提供了更长的保质期和可持续的药物释放。负载抗生素的核壳纤维平台可有效抑制革兰氏阳性菌和革兰氏阴性菌,而不会引起可观察到的细胞毒性。因此,PCL 涂层的 CL 纤维凝胶平台似乎是基于控制药物释放的伤口敷贴应用的良好候选物。